研究论文
Inhibition of histone lysine-specific demethylase 1 elicits breast tumor immunity and enhances antitumor efficacy of immune checkpoint blockade
Qin Ye, Shauna N. Vasilatos, Lin Chen, Hao Wu, Zhishen Cao, Yumei Fu, Min Huang, Anda Vlad 等 12 位
University of Pittsburgh Cancer Research Center UPMC Hillman Cancer Center Allegheny General Hospital
阅读操作
确认中在文库中上传 PDF 后可生成中文音频讲解。
摘要与影响
摘要 · 节选
暂未获取摘要。可打开原文或 PDF，后续可基于全文生成更完整的速读。
逐年被引趋势
40200
18
19
20
21
4022
23
24
25
26
关键指标
212
被引次数 · OpenAlex
5.36
领域内被引倍数
同类平均 = 1
同类平均 = 1
前 3%
引用位次
同领域 · 同年份 · 同类型
同领域 · 同年份 · 同类型
59
参考文献
Google Scholar 与 OpenAlex 的被引统计范围不同，数值存在差异属正常。
AI 辅助阅读
依据：文献信息
论文问答
当前基于文献信息回答
可就本文提问；依据不足时会说明。
学术脉络
学科主题
生物医学Epigenetics and DNA Methylation
Histone Deacetylase Inhibitors Research · Cancer Immunotherapy and Biomarkers
参考文献 59
B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion
被引 2,497Haidong Dong, Gefeng Zhu, Koji Tamada · Nature Medicine · 1999
The Programmed Death-1 Immune-Suppressive Pathway: Barrier to Antitumor Immunity
被引 245Suzanne Ostrand‐Rosenberg, Lucas A. Horn, Samuel Haile · The Journal of Immunology · 2014
MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer
被引 2,429Thomas Powles, Joseph P. Eder, Gregg Fine · Nature · 2014
此处列出前 3 条
引用本文 212
Regulatory mechanisms of PD-1/PD-L1 in cancers
被引 708Xin Lin, Kuan Kang, Pan Chen · Molecular Cancer · 2024
Targeting the epigenetic regulation of antitumour immunity
被引 641Simon J. Hogg, Paul A. Beavis, Mark A. Dawson · Nature Reviews Drug Discovery · 2020
Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise
被引 454Daphné Morel, Daniel Jeffery, Sandrine Aspeslagh · Nature Reviews Clinical Oncology · 2019
按被引量排序，此处列出前 3 条